Company Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide.
The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems.
In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions.
Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems.
It primarily serves the healthcare providers.
Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Country | GB |
IPO Date | Nov 16, 1999 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 18,000 |
CEO | Dr. Deepak S. Nath Ph.D. |
Contact Details
Address: Building 5 Watford, GB | |
Website | https://www.smith-nephew.com |
Stock Details
Ticker Symbol | SNN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000845982 |
CUSIP Number | 83175M205 |
ISIN Number | US83175M2052 |
Employer ID | 00-0000000 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Dr. Deepak S. Nath Ph.D. | Chief Executive Officer & Director |
John Terence Rogers | Chief Financial Officer & Executive Director |
Alison Parkes | Chief Compliance Officer & Compliance APAC |
Andrew Swift | Vice President of Investor Relations |
Dr. Vasant Padmanabhan Ph.D. | President of Research & Development and Ear, Nose & Throat |
Elga Lohler | Chief Human Resources Officer |
Helen Barraclough | Group General Counsel & Company Secretary |
Joe Metzger | Senior Vice President of Marketing Services & Communications |
Paul Connolly | President of Global Operations |
Philip G. Cowdy | Chief Corporate Development & Corporate Affairs Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 12, 2024 | 6-K | Filing |
Dec 11, 2024 | 6-K | Filing |
Dec 09, 2024 | 6-K | Filing |
Dec 06, 2024 | 6-K | Filing |
Dec 05, 2024 | 6-K | Filing |
Dec 05, 2024 | 6-K | Filing |
Dec 04, 2024 | 6-K | Filing |
Dec 02, 2024 | 6-K | Filing |
Nov 12, 2024 | 6-K | Filing |
Nov 01, 2024 | 6-K | Filing |